Naturally selected CD7 CAR-T cell therapy has tumor-killing effects based on in vitro and AML xenotransplantation models, whereas, it has no cytotoxic effects on normal myeloid cells (7). This evidence concerns the gene CD7 and acute myeloid leukemia.